Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Workers - Hazard via inhalation route

Systemic effects

Acute/short term exposure
DNEL related information

Local effects

Acute/short term exposure
DNEL related information

Workers - Hazard via dermal route

Systemic effects

Acute/short term exposure
DNEL related information

Workers - Hazard for the eyes

Additional information - workers

General Population - Hazard via inhalation route

Systemic effects

Acute/short term exposure
DNEL related information

Local effects

Acute/short term exposure
DNEL related information

General Population - Hazard via dermal route

Systemic effects

Acute/short term exposure
DNEL related information

General Population - Hazard via oral route

Systemic effects

Acute/short term exposure
DNEL related information

General Population - Hazard for the eyes

Additional information - General Population

On the basis that the results from the test material used in the acute oral toxicity study in rats, 3-(4-tert-butylphenyl)propionaldehyde used to the support the registration of 3-(4-tert-butylphenyl)acrylaldehyde using a read-across approach, 3-(4-tert-butylphenyl)acrylaldehyde should therefore also be considered as not acutely toxic by the oral route. In accordance with Regulation 1272/2008 and Directive 67/548/EEC, the substance does not meet the classification criteria for acute toxicity by the oral route.

On the basis that the results from the test material used in the in vivo skin irritation study in rabbits and the validated in vitro study (reconstructed human epidermis model), 3-(4-tert-butylphenyl)propionaldehyde, used to support the registration of 3-(4-tert-butylphenyl)acrylaldehyde using a read-across approach, 3-(4-tert-butylphenyl)acrylaldehyde should therefore

also be considered as a skin irritant. In accordance with Regulation 1272/2008 and Directive 67/548/EEC, the substance should be classified as H315 Causes skin irritation (Category 2) with the signal word 'Warning' and Xi R38 Irritating to skin, respectively.

On the basis that the results from the test material used in the skin sensitisation study (Mouse LLNA), 3-(4-tert-butylphenyl)propionaldehyde, are being used to the support the registration of 3-(4-tert-butylphenyl)acrylaldehyde using a read-across approach, 3-(4-tert-butylphenyl)acrylaldehyde should therefore also be considered to be sensitising to the skin.

In accordance with Regulation 1272/2008 and Directive 67/548/EEC, the substance should be classified as H317 May cause an allergic skin reaction (Subcategory 1B) with the signal word 'Warning' and Xi R43 May cause sensitisation by skin contact, respectively.

On the basis that the results from the reverse gene mutation study in bacteria performed with 3-(4-tert-butylphenyl)propionaldehyde, are being used to the support the registration of 3-(4-tert-butylphenyl)acrylaldehyde using a read-across approach, 3-(4-tert-butylphenyl)acrylaldehyde should therefore also be considered as not mutagenic in the reverse gene mutation assay in bacteria. The available information is not sufficient to determine the classification of the substance in accordance with Regulation 1272/2008 and Directive 67/548/EEC, for genetic toxicity as the available information does not include an evaluation of the cytogenicity of the substance.